BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27553616)

  • 21. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
    Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
    Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
    Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
    Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis.
    Lee JH; Jeong JU; Kim SH; Nam TK; Lee JH; Jeong S; Yu M; Jang HS
    Int J Colorectal Dis; 2019 Jan; 34(1):105-112. PubMed ID: 30350135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes.
    Lee JH; Kim SH; Kim JG; Cho HM; Shim BY
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):431-8. PubMed ID: 20732756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
    Sung S; Son SH; Park EY; Kay CS
    PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer.
    Ishihara S; Watanabe T; Kiyomatsu T; Yasuda K; Nagawa H
    Int J Colorectal Dis; 2010 Dec; 25(12):1417-25. PubMed ID: 20809426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
    Huang D; Lin Q; Song J; Xu B
    Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.
    Lee JH; Hyun JH; Kim DY; Yoo BC; Park JW; Kim SY; Chang HJ; Kim BC; Kim TH; Oh JH; Sohn DK
    Ann Surg Oncol; 2015 Jan; 22(1):209-15. PubMed ID: 25384698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
    Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
    Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
    Young Tabusso F; Payet Meza E; Celis Zapata J; Ruiz Figueroa E; Berrospi Espinoza F
    Rev Gastroenterol Peru; 2002; 22(3):213-20. PubMed ID: 12378215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels.
    Kim JY; Kim NK; Sohn SK; Kim YW; Kim KJ; Hur H; Min BS; Cho CH
    Ann Surg Oncol; 2009 Oct; 16(10):2771-8. PubMed ID: 19657698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Toiyama Y; Oki S; Okugawa Y; Ide S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Inoue Y; Araki T; Kusunoki M
    Oncology; 2018; 95(5):270-280. PubMed ID: 29996133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.